Literature DB >> 8931202

Models for empirical Bayes estimators of longitudinal CD4 counts.

M P LaValley1, V DeGruttola.   

Abstract

In this paper we consider the choice of model used in estimation of trajectories of CD4 T-cell counts by empirical Bayes estimators. Tsiatis et al. have demonstrated that empirical Bayes estimates of CD4 values correct for the bias resulting from measurement error when using CD4 as a covariate in a Cox model to predict clinical events. Here, empirical Bayes estimates from a random effects model are compared to estimates from the more general stochastic regression model presented in Taylor et al. Empirical Bayes estimators based on the two models are judged according to their ability to provide parameter estimates in a Cox model predicting clinical outcomes. Data from ACTG 118 are used as an illustration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931202     DOI: 10.1002/(SICI)1097-0258(19961115)15:21<2289::AID-SIM449>3.0.CO;2-I

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

Review 1.  Basic concepts and methods for joint models of longitudinal and survival data.

Authors:  Joseph G Ibrahim; Haitao Chu; Liddy M Chen
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

2.  Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.

Authors:  Danjie Zhang; Ming-Hui Chen; Joseph G Ibrahim; Mark E Boye; Ping Wang; Wei Shen
Journal:  Stat Med       Date:  2014-07-20       Impact factor: 2.373

3.  The quadratic hazard model for analyzing longitudinal data on aging, health, and the life span.

Authors:  A I Yashin; K G Arbeev; I Akushevich; A Kulminski; S V Ukraintseva; E Stallard; K C Land
Journal:  Phys Life Rev       Date:  2012-05-17       Impact factor: 11.025

4.  Missing data methods in longitudinal studies: a review.

Authors:  Joseph G Ibrahim; Geert Molenberghs
Journal:  Test (Madr)       Date:  2009-05-01       Impact factor: 2.345

5.  Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials.

Authors:  Danjie Zhang; Ming-Hui Chen; Joseph G Ibrahim; Mark E Boye; Wei Shen
Journal:  J Comput Graph Stat       Date:  2017-02-16       Impact factor: 2.302

6.  A Bayesian semiparametric survival model with longitudinal markers.

Authors:  Song Zhang; Peter Müller; Kim-Anh Do
Journal:  Biometrics       Date:  2009-06-08       Impact factor: 2.571

Review 7.  Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.

Authors:  A Lawrence Gould; Mark Ernest Boye; Michael J Crowther; Joseph G Ibrahim; George Quartey; Sandrine Micallef; Frederic Y Bois
Journal:  Stat Med       Date:  2014-03-14       Impact factor: 2.373

8.  Assessing Importance of Biomarkers: a Bayesian Joint Modeling Approach of Longitudinal and Survival Data with Semicompeting Risks.

Authors:  Fan Zhang; Ming-Hui Chen; Xiuyu Julie Cong; Qingxia Chen
Journal:  Stat Modelling       Date:  2020-07-27       Impact factor: 2.039

9.  Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study.

Authors:  Julius S Ngwa; Howard J Cabral; Debbie M Cheng; David R Gagnon; Michael P LaValley; L Adrienne Cupples
Journal:  BMC Med Res Methodol       Date:  2021-02-10       Impact factor: 4.615

10.  Improving quality indicator report cards through Bayesian modeling.

Authors:  Byron J Gajewski; Jonathan D Mahnken; Nancy Dunton
Journal:  BMC Med Res Methodol       Date:  2008-11-18       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.